Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

SillaJen (South Korea) | Researchclopedia

Back to institutions

SillaJen (South Korea)

Busancompany

33

Works

6,053

Citations

33

h-index

Top Research Topics

Virus-based gene therapy research Cancer Research and Treatments CAR-T cell therapy research

Top Researchers

David H. Kirn Alameda Applied Sciences Corporation (United States)

232 works21,774 citationsh-index: 73

Recent Research

Abstract PS3-13-06: Antitumor activity of the oncolytic virus JX-594 in patient-derived xenograft models of triple-negative breast cancer

J. Lee,Y. Kim,et al.

20260 citations

Immunotherapy and Immune Responses

Viral Infectious Diseases and Gene Expression in Insects

Cancer Immunotherapy and Biomarkers

Herpesvirus Infections and Treatments

Glioma Diagnosis and Treatment

Cancer Cells and Metastasis

Colorectal Cancer Treatments and Studies

Renal and related cancers

Gastrointestinal motility and disorders

Mi Kyung Kim Yonsei University

567 works9,770 citationsh-index: 50

Anne Moon Geisinger Medical Center

141 works9,312 citationsh-index: 52

James M. Burke Scripps Research Institute

147 works7,656 citationsh-index: 40

Caroline J. Breitbach

155 works6,071 citationsh-index: 34

Jin‐Sung Choi Pukyong National University

142 works4,971 citationsh-index: 38

CD55-displaying oncolytic vaccinia virus treated metastatic cancers by evading the effect of host innate and adaptive humoral responses

Eunhye Kim,Yeonsoo Yang,et al.

20260 citations

621 Optimizing immunomodulation of BAL0891, a TTK/PLK1 dual Inhibitor, to enhance synergy with immune checkpoint blockade using a biomimetic tumor microenvironment platform and pharmacometric modeling

Seunghoon Han,Sang Jin Lee,et al.

20250 citations

BAP1 as a predictive biomarker of therapeutic response to oncolytic vaccinia virus for metastatic renal cell carcinoma therapy

Jee Soo Park,Won Sik Jang,et al.

20253 citations

Abstract 2169: TTK/PLK1 dual antagonist BAL0891 synergizes with pembrolizumab in a vascularized 3D tumor microenvironment model

Junfeng Wang,Min-Kyung Kang,et al.

20251 citations

Abstract 3017: Profiling patient response to TTK/PLK1 dual antagonist BAL0891 using 3D patient-derived organoid model in a microphysiological system

Junfeng Wang,Min-Kyung Kang,et al.

20250 citations